Solid Biosciences Inc (NAS:SLDB)
$ 9.12 0.17 (1.9%) Market Cap: 350.02 Mil Enterprise Value: 163.25 Mil PE Ratio: 0 PB Ratio: 1.64 GF Score: 40/100

Q1 2022 Solid Biosciences Inc Earnings Call Transcript

Apr 27, 2022 / 12:00PM GMT
Release Date Price: $9.65 (-16.98%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Solid Biosciences Strategic Business Update and Financial Results Conference Call. (Operator Instructions)

I would now like to hand the conference over to Caitlin Lowie, Vice President of Communications and Investor Relations at Solid Biosciences. Ms. Lowie, you may begin.

Caitlin Lowie
Solid Biosciences Inc. - VP of Communications & IR

Good morning. Thank you, operator. Before we get started, I would like to remind everyone that during today's conference call, we may make forward-looking statements, including statements about the company's financial results, financial guidance, future business strategies and operations and product development and regulatory progress, including statements about the company's IGNITE DMD clinical trial. Actual results could differ materially from those discussed in these forward-looking statements due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process. The extent and duration of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot